US equities |
INTC $119.13 ▼-0.17% MU $1,074.89 ▲+0.00% SNDK $1,719.99 ▲+0.00% NVDA $233.95 ▲+0.00% SPCX $158.96 ▲+0.00% AMD $633.91 ▲+0.00% MSTR $160.01 ▲+0.00% ASML $1,867.31 ▲+0.00%
FinancialContent

Articles published by Asahi Kasei Pharma

News headline image
Asahi Kasei Pharma Starts Phase III Study of Promising CIPN Prevention Therapy, ART-123 (Recomodulin™), to Enhance Treatment Options Worldwide
From Asahi Kasei Pharma
Via Business Wire
Tickers AHKSY OTC
News headline image
Asahi Kasei Pharma Strengthens Global Reach with Exclusive License Agreement for anti-CX3CR1 Antibody
From Asahi Kasei Pharma
Via Business Wire
Tickers AHKSY OTC
News headline image
Asahi Kasei Pharma to Sponsor Research for Drug Discovery Research and Technology: Open Innovation 2023
From Asahi Kasei Pharma
Via Business Wire
Tickers AHKSY OTC